Difference between revisions of "Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study"

From Clinfowiki
Jump to: navigation, search
(Created page with "== Background == == Methods == == Results == == Conclusions == == Appendix == == References == <references/> Category: Reviews")
 
(→‎Appendix)
Line 8: Line 8:
  
 
== Appendix ==
 
== Appendix ==
 +
* Lab measurement frequency and range targets used in the analysis. <ref name="Lab Measurement"> Lab measurement frequency and range targets used in the analysis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab1/ </ref>
 +
* Baseline patient characteristics. <ref name="Baseline Patient Characteristics"> Baseline patient characteristics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab2/ </ref>
 +
* Estimated odds ratio for ordering laboratory tests within guideline-recommended intervals: CDSS vs Controls. <ref name="Ordering Laboratory Tests">  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab3/ </ref>
 +
* Effect of CDSS on adherence to guideline testing intervals for eGFR. <ref name="eGFR"> Effect of CDSS on adherence to guideline testing intervals for eGFR. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig1/ </ref>
 +
* Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). <ref name="phosphorus (a) and PTH (b)"> Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig2/ </ref>
 +
* Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). <ref name="LDL-C (a) and Urine Panels (b)"> Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig3/ </ref>
 +
* Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). <ref name="LDL cholesterol"> Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/</ref>
 +
* Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. <ref name="Achieving CDSS vs Controls">  Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/ </ref>
  
 
== References ==
 
== References ==

Revision as of 01:50, 22 October 2015

Background

Methods

Results

Conclusions

Appendix

  • Lab measurement frequency and range targets used in the analysis. [1]
  • Baseline patient characteristics. [2]
  • Estimated odds ratio for ordering laboratory tests within guideline-recommended intervals: CDSS vs Controls. [3]
  • Effect of CDSS on adherence to guideline testing intervals for eGFR. [4]
  • Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). [5]
  • Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). [6]
  • Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). [7]
  • Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. [8]

References

  1. ↑ Lab measurement frequency and range targets used in the analysis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab1/
  2. ↑ Baseline patient characteristics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab2/
  3. ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab3/
  4. ↑ Effect of CDSS on adherence to guideline testing intervals for eGFR. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig1/
  5. ↑ Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig2/
  6. ↑ Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig3/
  7. ↑ Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/
  8. ↑ Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/
Retrieved from "http://www.clinfowiki.org/wiki/index.php?title=Clinical_decision_support_improves_physician_guideline_adherence_for_laboratory_monitoring_of_chronic_kidney_disease:_a_matched_cohort_study&oldid=27937"